333
Participants
Start Date
November 7, 2016
Primary Completion Date
April 2, 2024
Study Completion Date
April 2, 2024
REGN3767
cemiplimab
Peter Maccallum Cancer Centre (PMCC), Melbourne
Royal Brisbane and Women's Hospital, Brisbane
Laura & Isaac Perlmutter Cancer Center, New York
Columbia University, New York
Memorial Sloan-Kettering Cancer Center, New York
Northwell Health-Monter Cancer Center, Lake Success
Roswell Park Cancer Institute, Buffalo
Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital, Washington D.C.
Virginia Cancer Care Specialist, PC, Fairfax
Levine Cancer Institute, Charlotte
Hollings Cancer Center - Medical University of South Carolina, Charleston
Winship Cancer Institute at Emory University, Atlanta
Orlando Health, Inc, Orlando
Miami Cancer Institute, Miami
Sarah Cannon Research Institute, Nashville
University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland
Henry Ford Health Hospital, Detroit
Cancer and Hematology Centers of Western Michigan, Grand Rapids
Washington University in Saint Louis, St Louis
University of Kansas Clinical Research Center, Fairway
Stephenson Cancer Center, Oklahoma City
The University of Texas MD Anderson Cancer Center, Houston
South Texas Oncology and Hematology, San Antonio
University of Colorado Cancer Center, Aurora
New Mexico Cancer Care Alliance-UNM Cancer Center, Albuquerque
The Angeles Clinic, Los Angeles
California Cancer Associates for Research and Excellence, Encinitas
California Cancer Associates For Research And Excellence, Fresno
California Pacific Medical Center (CPMC), San Francisco
University of California Davis Health Systems, Sacramento
University of California San Diego (UCSD), La Jolla
Dana Farber Cancer Institute, Jamaica Plain
John Theurer Cancer Center, Hackensack University Medical Center, Hackensack
Rutgers Cancer Institute of New Jersey, New Brunswick
Rhode Island Hospital, Providence
The University of Western Australia - The Queen Elizabeth II Medical Centre (QEIIMC) - Sir Charles Gairdner Hospital (SCGH), Perth
St. Vincents University Hospital, Dublin
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Guy's Hospital, London
University Of Oxford - Churchill Hospital, Headington
Regeneron Pharmaceuticals
INDUSTRY